The First Report of The Latin American Society of Nephrology and Hypertension (SLANH) Anemia Committee in Chronic Hemodialysis Patients
- Autores: Raúl G. Carlini, Gregorio Obrador, Nieves Campistrús, LIliana Andrade, Liliana Chifflet, Rachel Bregman, Alberto Locatelli, Ricardo Correa Rotter, Hugo Poblete
- Localización: Nefrología: publicación oficial de la Sociedad Española de Nefrología, ISSN 0211-6995, Vol. 34, Nº. 1, 2014, págs. 96-104
- Idioma: inglés
- Enlaces
-
Resumen
Background:
Anemia almost invariably occurs in patients with chronic kidney disease. Limited data are available re - garding anemia management in Latin American (LA) he - modialysis (HD) patients.
Objective:
To evaluate the results of the first anemia survey of the Anemia Committee of the SLANH.
Methods:
This is a multinational, voluntary survey that collected anemia management data from adult HD patients from independent, non-chain owned HD units, between 09/2009 and 03/2010. T-test, ANOVA, chi-square test and multivariate logistic regression were used for statistical analysis.
Results:
The survey received responses from 134 HD units of 16 countries providing data from 9,025 patients. Mean values of Hb, ferritin, and transfer - rin saturation (TSAT) were 10.5±1.8g/dL, 570±539?g/L, and 29.8±15%, respectively. Only 32.7% of patients were with - in the Hb target of 10.5-12.0g/dL (46.3% were below and 21.1% above). Erythropoietin-stimulating agents (ESAs) were administered to 84.3% patients and 68.3% received intravenous iron (IV). Iron deficiency (TSAT < 20%) was pres - ent in 27.5% patients and among those receiving eryth - ropoietin, 47% did not achieve Hb target. The indepen dent variables associated with the lowest Hb level (<10.5g/ dL) were: female gender, TSAT<25% and age<50 years.
Conclusions:
According to these results, nearly half of LA chronic HD patients did not achieve the rPecommended Hb target despite wide use of ESAs and IV iron
